» Authors » Ming-X Tang

Ming-X Tang

Explore the profile of Ming-X Tang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 740
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharp M, Caccappolo E, Mejia-Santana H, Tang M, Rosado L, Orbe Reilly M, et al.
Mov Disord . 2014 Nov; 30(2):278-83. PMID: 25393808
Background: Few studies have systematically investigated the association between PARKIN genotype and psychiatric co-morbidities of Parkison's disease (PD). PARKIN-associated PD is characterized by severe nigral dopaminergic neuronal loss, a finding...
2.
Gupte M, Alcalay R, Mejia-Santana H, Raymond D, Saunders-Pullman R, Roos E, et al.
J Genet Couns . 2014 Aug; 24(2):238-46. PMID: 25127731
Our objective was to explore interest in genetic testing among Ashkenazi Jewish (AJ) Parkinson's Disease (PD) cases and first-degree relatives, as genetic testing for LRRK2 G2019S is widely available. Approximately...
3.
Alcalay R, Mirelman A, Saunders-Pullman R, Tang M, Mejia Santana H, Raymond D, et al.
Mov Disord . 2013 Nov; 28(14):1966-71. PMID: 24243757
The phenotype of Parkinson's disease (PD) in patients with and without leucine-rich repeat kinase 2 (LRRK2) G2019S mutations reportedly is similar; however, large, uniformly evaluated series are lacking. The objective...
4.
Huey E, Manly J, Tang M, Schupf N, Brickman A, Manoochehri M, et al.
Alzheimers Dement . 2013 Mar; 9(6):632-9. PMID: 23452959
Background: Amnestic mild cognitive impairment (aMCI) is associated with an elevated risk of progressing to Alzheimer's disease. Much less is known about the course of dysexecutive mild cognitive impairment (dMCI)....
5.
Manly J, Schupf N, Stern Y, Brickman A, Tang M, Mayeux R
Arch Neurol . 2011 May; 68(5):607-14. PMID: 21555635
Background: Telephone-based interviews can be used for screening and to obtain key study outcomes when participants in longitudinal studies die or cannot be seen in person, but must be validated...
6.
Caccappolo E, Alcalay R, Mejia-Santana H, Tang M, Rakitin B, Rosado L, et al.
J Int Neuropsychol Soc . 2010 Nov; 17(1):91-100. PMID: 21092386
The cognitive profile of early onset Parkinson's disease (EOPD) has not been clearly defined. Mutations in the parkin gene are the most common genetic risk factor for EOPD and may...
7.
Manly J, Tang M, Schupf N, Stern Y, Vonsattel J, Mayeux R
Ann Neurol . 2008 Feb; 63(4):494-506. PMID: 18300306
Objective: To examine incidence rates and antecedents of mild cognitive impairment (MCI) and Alzheimer's disease (AD) among diverse elders without dementia at the initial visit, and to examine the characteristics...
8.
Johnson B, Santana V, Schupf N, Tang M, Stern Y, Mayeux R, et al.
Dement Geriatr Cogn Disord . 2007 Oct; 24(6):411-7. PMID: 17938569
Background: Alzheimer disease (AD) is under substantial genetic influence. To better understand the genetic influence on component phenotypes of AD, we estimated the heritability (h(2)) of abstract reasoning and examined...
9.
Manly J, Schupf N, Tang M, Stern Y
J Geriatr Psychiatry Neurol . 2005 Nov; 18(4):213-7. PMID: 16306242
Researchers on genetic and environmental influences on risk for Alzheimer's disease must be prepared for the growing ethnic and racial diversity of our participants. Within the investigation, years of education...
10.
Manly J, Bell-McGinty S, Tang M, Schupf N, Stern Y, Mayeux R
Arch Neurol . 2005 Nov; 62(11):1739-46. PMID: 16286549
Background: Reported rates of mild cognitive impairment (MCI) range widely depending on methodologic differences, including specific sample characteristics, cognitive measures used, normative samples used for neuropsychological tests, and diagnostic criteria....